Rainer Schulz - Biography#

Rainer Schulz (born 1963) graduated in Medicine from the University of Essen in 1992, where he obtained his M.D. degree. He was an Invited Researcher at the School of Medicine of the UCSD, where his research interests focused on cardiac function during acute and chronic ischemia. Here he developed the concept of the inotropic reserve of chronically ischemic myocardium (hibernation), a method clinically used to identify these patient cohort.

From 1996 to 2010 he had established and led an independent research group within the Department of Pathophysiology, University of Essen, Medical School, and since January 2011 he has been appointed as Chairman of Physiology at the Justus-Liebig University Giessen. Here he achieved international recognition for his research on myocardial ischemia/reperfusion injury (IRI) and protection from it, using a translational approach from subcellular particles towards large animal model to define new targets involved in IRI and investigate novel treatment strategies for protecting the heart. More recently he focused his research on the importance of mitochondrial derived reactive oxygen species for IRI and protection from it as well as pulmonary hypertension.

He is also a Member of numerous international scientific societies, Editorial Boards and reviewer for many journals and funding agencies. Dr Schulz is Senior Editor of the British Journal of Pharmacology.